{"id": "article-43836_0", "title": "Soft Tissue Clear Cell Sarcoma -- Continuing Education Activity", "content": "Clear cell sarcoma of soft tissue (CCSST) is an exceedingly rare tumor that originates from neural crest cells and is histologically characterized by clear cells that contain accumulated glycogen. These tumors share histological and immunohistochemical characteristics with malignant melanoma. They commonly arise from tendinous sheaths and aponeuroses, with the majority described in the lower limbs, particularly around the ankles. Tumors arising in the upper extremities are rare. A few primary clear cell sarcoma cases of soft tissue have been described arising from the chest wall and scapular soft tissues. This activity reviews the presentation, evaluation, and management of clear cell sarcoma of soft tissue and stresses the role of an interprofessional team approach to care for affected patients.", "contents": "Soft Tissue Clear Cell Sarcoma -- Continuing Education Activity. Clear cell sarcoma of soft tissue (CCSST) is an exceedingly rare tumor that originates from neural crest cells and is histologically characterized by clear cells that contain accumulated glycogen. These tumors share histological and immunohistochemical characteristics with malignant melanoma. They commonly arise from tendinous sheaths and aponeuroses, with the majority described in the lower limbs, particularly around the ankles. Tumors arising in the upper extremities are rare. A few primary clear cell sarcoma cases of soft tissue have been described arising from the chest wall and scapular soft tissues. This activity reviews the presentation, evaluation, and management of clear cell sarcoma of soft tissue and stresses the role of an interprofessional team approach to care for affected patients."}
{"id": "article-43836_1", "title": "Soft Tissue Clear Cell Sarcoma -- Continuing Education Activity", "content": "Objectives: Describe the classic histopathological findings in clear cell sarcoma of soft tissue. Outline risk factors for the development of clear cell sarcoma of soft tissue. Explain the physical exam findings associated with clear cell sarcoma of soft tissue. Describe the importance of improving communication amongst interprofessional team members to enhance care for patients affected by clear cell sarcoma of soft tissue. Access free multiple choice questions on this topic.", "contents": "Soft Tissue Clear Cell Sarcoma -- Continuing Education Activity. Objectives: Describe the classic histopathological findings in clear cell sarcoma of soft tissue. Outline risk factors for the development of clear cell sarcoma of soft tissue. Explain the physical exam findings associated with clear cell sarcoma of soft tissue. Describe the importance of improving communication amongst interprofessional team members to enhance care for patients affected by clear cell sarcoma of soft tissue. Access free multiple choice questions on this topic."}
{"id": "article-43836_2", "title": "Soft Tissue Clear Cell Sarcoma -- Introduction", "content": "Clear cell sarcoma of\u00a0soft tissue (CCSST) is an exceedingly rare tumor that originates from neural crest cells and is histologically characterized\u00a0by clear cells representing intracellular glycogen accumulation. [1] [2] [3] These tumors share histological and immunohistochemical characteristics with malignant melanoma (MM). [2] They commonly arise from tendinous sheaths and aponeuroses, with the majority described in the lower limbs, particularly around the ankles. [4] Tumors arising in the upper extremities are rare, and very\u00a0few cases of primary CCSST have been described\u00a0as arising in the chest wall and scapular soft tissues. [5] [6]", "contents": "Soft Tissue Clear Cell Sarcoma -- Introduction. Clear cell sarcoma of\u00a0soft tissue (CCSST) is an exceedingly rare tumor that originates from neural crest cells and is histologically characterized\u00a0by clear cells representing intracellular glycogen accumulation. [1] [2] [3] These tumors share histological and immunohistochemical characteristics with malignant melanoma (MM). [2] They commonly arise from tendinous sheaths and aponeuroses, with the majority described in the lower limbs, particularly around the ankles. [4] Tumors arising in the upper extremities are rare, and very\u00a0few cases of primary CCSST have been described\u00a0as arising in the chest wall and scapular soft tissues. [5] [6]"}
{"id": "article-43836_3", "title": "Soft Tissue Clear Cell Sarcoma -- Etiology", "content": "While the major cause of these tumors remains unknown, several risks\u00a0have been described for soft tissue sarcomas, such as genetic predisposition, radiation therapy, lymphedema, gene mutations, and chemotherapy. [3]", "contents": "Soft Tissue Clear Cell Sarcoma -- Etiology. While the major cause of these tumors remains unknown, several risks\u00a0have been described for soft tissue sarcomas, such as genetic predisposition, radiation therapy, lymphedema, gene mutations, and chemotherapy. [3]"}
{"id": "article-43836_4", "title": "Soft Tissue Clear Cell Sarcoma -- Etiology", "content": "Clear cell sarcoma was initially described as \u201cmalignant melanoma of soft parts\u201d due to their histological similarities. Both share immunohistochemical markers, and their\u00a0gene expression profiling suggests that CCSST are a\u00a0genomic subtype of MM. [7] Unlike MM, however, most clear cell sarcomas are associated\u00a0with a\u00a0t(12;22)(q13-14;q12) translocation. [8] [9]", "contents": "Soft Tissue Clear Cell Sarcoma -- Etiology. Clear cell sarcoma was initially described as \u201cmalignant melanoma of soft parts\u201d due to their histological similarities. Both share immunohistochemical markers, and their\u00a0gene expression profiling suggests that CCSST are a\u00a0genomic subtype of MM. [7] Unlike MM, however, most clear cell sarcomas are associated\u00a0with a\u00a0t(12;22)(q13-14;q12) translocation. [8] [9]"}
{"id": "article-43836_5", "title": "Soft Tissue Clear Cell Sarcoma -- Epidemiology", "content": "The true incidence of this tumor remains unknown. It is more common in Caucasians and estimated that men and women are equally affected with a median age of 39 years,\u00a0with rare cases reported in children. [4] [9] It typically arises in the lower extremities, particularly around the foot and ankle. However, rare presentations in the kidney, trunk, penis, gastrointestinal tract, head, and neck have\u00a0been described. [10] The 5- and 10-year overall survival for clear cell sarcoma is estimated to be 50% and 38% respectively, with later stages (III and IV) having a worse survival rate. [1] [2] [3]", "contents": "Soft Tissue Clear Cell Sarcoma -- Epidemiology. The true incidence of this tumor remains unknown. It is more common in Caucasians and estimated that men and women are equally affected with a median age of 39 years,\u00a0with rare cases reported in children. [4] [9] It typically arises in the lower extremities, particularly around the foot and ankle. However, rare presentations in the kidney, trunk, penis, gastrointestinal tract, head, and neck have\u00a0been described. [10] The 5- and 10-year overall survival for clear cell sarcoma is estimated to be 50% and 38% respectively, with later stages (III and IV) having a worse survival rate. [1] [2] [3]"}
{"id": "article-43836_6", "title": "Soft Tissue Clear Cell Sarcoma -- Pathophysiology", "content": "Clear-cell sarcoma of soft tissue appears as a macroscopically tan-gray\u00a0firm mass. [4] [9] With a size that may range from 0.4 to 14.5 cm, it commonly shows infiltration along with the tendons and aponeuroses. Immunohistochemical studies commonly show neoplastic cells positive with HMB-45, S100 protein, and\u00a0Melan-A. Most cases\u00a0exhibit a t(12;22)(q13;q12) translocation causing an EWSR1/ATF1 gene fusion, a finding that\u00a0helps differentiate these\u00a0lesions from MM. [4]", "contents": "Soft Tissue Clear Cell Sarcoma -- Pathophysiology. Clear-cell sarcoma of soft tissue appears as a macroscopically tan-gray\u00a0firm mass. [4] [9] With a size that may range from 0.4 to 14.5 cm, it commonly shows infiltration along with the tendons and aponeuroses. Immunohistochemical studies commonly show neoplastic cells positive with HMB-45, S100 protein, and\u00a0Melan-A. Most cases\u00a0exhibit a t(12;22)(q13;q12) translocation causing an EWSR1/ATF1 gene fusion, a finding that\u00a0helps differentiate these\u00a0lesions from MM. [4]"}
{"id": "article-43836_7", "title": "Soft Tissue Clear Cell Sarcoma -- Histopathology", "content": "On microscopy, the neoplastic cells show abundant cytoplasm containing numerous mitochondria. Cells are commonly polygonal and fusiform with clear cytoplasm and a centrally located round nucleus. The \"clear-cell\" appearance represents intracellular\u00a0glycogen accumulation, as\u00a0demonstrated by the periodic acid-Schiff stain. Pigmented and unpigmented melanosomes, scattered multinucleated giant cells, and areas of focal necrosis are also commonly present. CCSST commonly show highly infiltrative cells, haphazardly organized into compact nests and fascicles that dissect along with dense fibrous connective tissue. [4]", "contents": "Soft Tissue Clear Cell Sarcoma -- Histopathology. On microscopy, the neoplastic cells show abundant cytoplasm containing numerous mitochondria. Cells are commonly polygonal and fusiform with clear cytoplasm and a centrally located round nucleus. The \"clear-cell\" appearance represents intracellular\u00a0glycogen accumulation, as\u00a0demonstrated by the periodic acid-Schiff stain. Pigmented and unpigmented melanosomes, scattered multinucleated giant cells, and areas of focal necrosis are also commonly present. CCSST commonly show highly infiltrative cells, haphazardly organized into compact nests and fascicles that dissect along with dense fibrous connective tissue. [4]"}
{"id": "article-43836_8", "title": "Soft Tissue Clear Cell Sarcoma -- Histopathology", "content": "Immunohistochemistry shows antigens commonly associated with melanin synthesis, including HMB-45 and S100 within the cytoplasm and nucleus. It may also show positivity for CD99, Melan-A, neuron-specific enolase, and vimentin. [4] [8] Cytokeratin, epithelial membrane antigen, carcinoembryonic antigen, desmin, and smooth muscle actin are usually negative. [4] [8]", "contents": "Soft Tissue Clear Cell Sarcoma -- Histopathology. Immunohistochemistry shows antigens commonly associated with melanin synthesis, including HMB-45 and S100 within the cytoplasm and nucleus. It may also show positivity for CD99, Melan-A, neuron-specific enolase, and vimentin. [4] [8] Cytokeratin, epithelial membrane antigen, carcinoembryonic antigen, desmin, and smooth muscle actin are usually negative. [4] [8]"}
{"id": "article-43836_9", "title": "Soft Tissue Clear Cell Sarcoma -- History and Physical", "content": "Most patients present in their thirties and forties. While CCSST commonly appears in the legs or thighs as a small tender spot or swelling,\u00a0some patients may present involvement of the subcutaneous tissue and adjacent dermis and may present with ulceration of the overlying skin. [4] Rare presentations of CCSST have also been documented in other sites, including the lumbar region, parapharyngeal tissue,\u00a0penis,\u00a0and neck. [11] [12] [13] [14] [15]", "contents": "Soft Tissue Clear Cell Sarcoma -- History and Physical. Most patients present in their thirties and forties. While CCSST commonly appears in the legs or thighs as a small tender spot or swelling,\u00a0some patients may present involvement of the subcutaneous tissue and adjacent dermis and may present with ulceration of the overlying skin. [4] Rare presentations of CCSST have also been documented in other sites, including the lumbar region, parapharyngeal tissue,\u00a0penis,\u00a0and neck. [11] [12] [13] [14] [15]"}
{"id": "article-43836_10", "title": "Soft Tissue Clear Cell Sarcoma -- Evaluation", "content": "The initial evaluation should include a complete history and physical examination. As previously discussed, most patients will present with a small swelling or tender spot in the lower extremities, particularly in an ankle. [16] Patients should be asked\u00a0about when the mass was noticed, the pattern of growth, and evaluated for signs and symptoms that may help in early staging. Physical examination should be focused on determining size, depth, fixation to adjacent tissues, edema, or possible neurovascular compromise. [4] Soft tissue sarcomas, in general,\u00a0can be divided into subtypes, and no single imaging modality is ideal for every tumor. [4] [17]", "contents": "Soft Tissue Clear Cell Sarcoma -- Evaluation. The initial evaluation should include a complete history and physical examination. As previously discussed, most patients will present with a small swelling or tender spot in the lower extremities, particularly in an ankle. [16] Patients should be asked\u00a0about when the mass was noticed, the pattern of growth, and evaluated for signs and symptoms that may help in early staging. Physical examination should be focused on determining size, depth, fixation to adjacent tissues, edema, or possible neurovascular compromise. [4] Soft tissue sarcomas, in general,\u00a0can be divided into subtypes, and no single imaging modality is ideal for every tumor. [4] [17]"}
{"id": "article-43836_11", "title": "Soft Tissue Clear Cell Sarcoma -- Evaluation", "content": "In addition to plain radiographs, which are useful to evaluate for possible masses arising from bone, or to detect intralesional calcifications, cross-sectional imaging with magnetic resonance imaging (MRI) is commonly preferred for masses that arise in the extremities. MRI, unlike CT, delineates different muscle groups and may provide more information regarding the extent of these tumors. [18] [19] CT may provide useful information on metastatic disease, particularly if the patient has a large (greater than 5 cm) or deep-seated tumor. [20]", "contents": "Soft Tissue Clear Cell Sarcoma -- Evaluation. In addition to plain radiographs, which are useful to evaluate for possible masses arising from bone, or to detect intralesional calcifications, cross-sectional imaging with magnetic resonance imaging (MRI) is commonly preferred for masses that arise in the extremities. MRI, unlike CT, delineates different muscle groups and may provide more information regarding the extent of these tumors. [18] [19] CT may provide useful information on metastatic disease, particularly if the patient has a large (greater than 5 cm) or deep-seated tumor. [20]"}
{"id": "article-43836_12", "title": "Soft Tissue Clear Cell Sarcoma -- Evaluation", "content": "Histology is essential for planning further workup and treatment. Tissue may be obtained through incisional biopsy, fine needle aspiration, or core needle biopsy. The latter has a lower incidence of complications, is highly accurate, and is usually preferred. [21]", "contents": "Soft Tissue Clear Cell Sarcoma -- Evaluation. Histology is essential for planning further workup and treatment. Tissue may be obtained through incisional biopsy, fine needle aspiration, or core needle biopsy. The latter has a lower incidence of complications, is highly accurate, and is usually preferred. [21]"}
{"id": "article-43836_13", "title": "Soft Tissue Clear Cell Sarcoma -- Evaluation", "content": "Further pathological workup for CCSST should include immunohistochemistry. Confirmation of CCSST and differentiating this tumor from MM will also require fluorescence in situ hybridization (FISH) or reverse transcription-polymerase chain reaction (RT-PCR). [10]", "contents": "Soft Tissue Clear Cell Sarcoma -- Evaluation. Further pathological workup for CCSST should include immunohistochemistry. Confirmation of CCSST and differentiating this tumor from MM will also require fluorescence in situ hybridization (FISH) or reverse transcription-polymerase chain reaction (RT-PCR). [10]"}
{"id": "article-43836_14", "title": "Soft Tissue Clear Cell Sarcoma -- Evaluation", "content": "After treatment, discussed below, postoperative imaging is commonly performed\u00a03 months after treatment. For high-grade lesions on presentation, 3- to 6-month\u00a0interval imaging is preferred, while low-grade lesions may be followed with annual imaging. [19] [20] [21]", "contents": "Soft Tissue Clear Cell Sarcoma -- Evaluation. After treatment, discussed below, postoperative imaging is commonly performed\u00a03 months after treatment. For high-grade lesions on presentation, 3- to 6-month\u00a0interval imaging is preferred, while low-grade lesions may be followed with annual imaging. [19] [20] [21]"}
{"id": "article-43836_15", "title": "Soft Tissue Clear Cell Sarcoma -- Treatment / Management", "content": "For localized lesions, the treatment of choice is wide surgical resection with negative margins. [16] [22] If complete excision is achieved, adjuvant therapy is typically unnecessary as there is no\u00a0significant improvement in survival. [6] [23] Intralesional excision has been associated with higher recurrence rates. [23] [24]", "contents": "Soft Tissue Clear Cell Sarcoma -- Treatment / Management. For localized lesions, the treatment of choice is wide surgical resection with negative margins. [16] [22] If complete excision is achieved, adjuvant therapy is typically unnecessary as there is no\u00a0significant improvement in survival. [6] [23] Intralesional excision has been associated with higher recurrence rates. [23] [24]"}
{"id": "article-43836_16", "title": "Soft Tissue Clear Cell Sarcoma -- Treatment / Management", "content": "Radiotherapy may improve outcomes in patients who undergo\u00a0close resection margins. [23] [24] Chemotherapy is primarily employed in patients with metastatic disease. Cisplatin-based and caffeine-assisted chemotherapy with doxorubicin and cisplatin may benefit patients with metastatic disease or large tumors on presentation. [23]", "contents": "Soft Tissue Clear Cell Sarcoma -- Treatment / Management. Radiotherapy may improve outcomes in patients who undergo\u00a0close resection margins. [23] [24] Chemotherapy is primarily employed in patients with metastatic disease. Cisplatin-based and caffeine-assisted chemotherapy with doxorubicin and cisplatin may benefit patients with metastatic disease or large tumors on presentation. [23]"}
{"id": "article-43836_17", "title": "Soft Tissue Clear Cell Sarcoma -- Treatment / Management", "content": "After surgical excision, patients should be followed closely due to the high rates of recurrence. Patients with higher risk may benefit from close interval imaging, while lower-risk patients may be followed with yearly imaging. [2] [6] [22]", "contents": "Soft Tissue Clear Cell Sarcoma -- Treatment / Management. After surgical excision, patients should be followed closely due to the high rates of recurrence. Patients with higher risk may benefit from close interval imaging, while lower-risk patients may be followed with yearly imaging. [2] [6] [22]"}
{"id": "article-43836_18", "title": "Soft Tissue Clear Cell Sarcoma -- Differential Diagnosis", "content": "The differential diagnoses of a tumor located\u00a0in the proximity of tendons and aponeurosis should include paraganglioma-like dermal melanocytic tumor, MM, malignant peripheral nerve sheath tumor, synovial sarcoma, and clear cell myomelanocytic tumor. [6] [23]", "contents": "Soft Tissue Clear Cell Sarcoma -- Differential Diagnosis. The differential diagnoses of a tumor located\u00a0in the proximity of tendons and aponeurosis should include paraganglioma-like dermal melanocytic tumor, MM, malignant peripheral nerve sheath tumor, synovial sarcoma, and clear cell myomelanocytic tumor. [6] [23]"}
{"id": "article-43836_19", "title": "Soft Tissue Clear Cell Sarcoma -- Differential Diagnosis", "content": "Compared to MM, CCSST usually occurs in the younger patient population, is located in deeper tissues, is associated with aponeuroses or tendons, and commonly lacks epidermal involvement. [23] Additionally,\u00a0the\u00a0t(12;22)\u00a0translocation\u00a0seen in CCSST has not\u00a0been observed in malignant MM. However, there may be significant histologic overlap. Synovial\u00a0sarcoma commonly shows a\u00a0t(X;18)(p11.2;q11.2) translocation producing SYT/SSX1 or SYT/sSSX2 gene fusions, not seen in CCSST. [6] [23] Paraganglioma-like dermal melanocytic tumor primarily presents in the extremities of female patients as a dermal nodule. On microscopy, it shows oval-cells arranged in packet-like groups. [6]", "contents": "Soft Tissue Clear Cell Sarcoma -- Differential Diagnosis. Compared to MM, CCSST usually occurs in the younger patient population, is located in deeper tissues, is associated with aponeuroses or tendons, and commonly lacks epidermal involvement. [23] Additionally,\u00a0the\u00a0t(12;22)\u00a0translocation\u00a0seen in CCSST has not\u00a0been observed in malignant MM. However, there may be significant histologic overlap. Synovial\u00a0sarcoma commonly shows a\u00a0t(X;18)(p11.2;q11.2) translocation producing SYT/SSX1 or SYT/sSSX2 gene fusions, not seen in CCSST. [6] [23] Paraganglioma-like dermal melanocytic tumor primarily presents in the extremities of female patients as a dermal nodule. On microscopy, it shows oval-cells arranged in packet-like groups. [6]"}
{"id": "article-43836_20", "title": "Soft Tissue Clear Cell Sarcoma -- Differential Diagnosis", "content": "Clear cell myomelanocytic tumor belongs to a family of tumors known as perivascular epithelioid cell family of tumors, which present commonly in the abdomen, usually in the ligamentum teres of the liver of young patients. Malignant peripheral nerve sheath tumor usually arises within large peripheral nerves and is negative for HMB-45. [6]", "contents": "Soft Tissue Clear Cell Sarcoma -- Differential Diagnosis. Clear cell myomelanocytic tumor belongs to a family of tumors known as perivascular epithelioid cell family of tumors, which present commonly in the abdomen, usually in the ligamentum teres of the liver of young patients. Malignant peripheral nerve sheath tumor usually arises within large peripheral nerves and is negative for HMB-45. [6]"}
{"id": "article-43836_21", "title": "Soft Tissue Clear Cell Sarcoma -- Prognosis", "content": "CCSST is associated with an overall poor prognosis. A study with 75 patients showed a 69% and 21% metastatic disease and local recurrence rate, respectively. The overall 5-year survival rate was 47% and 36% for 10-years. Furthermore, for\u00a0patients who presented localized disease, the overall survival was 55% and 41% at 5 and 10 years, respectively. [22] A case series with 52 patients showed a survival rate of 59% and 41% at 5 years and 10 years. [2] Significant prognostic factors include tumor size, depth, and TNM classification. However, after multivariate analysis, only tumor size has remained a significant prognostic factor. [6] [22]", "contents": "Soft Tissue Clear Cell Sarcoma -- Prognosis. CCSST is associated with an overall poor prognosis. A study with 75 patients showed a 69% and 21% metastatic disease and local recurrence rate, respectively. The overall 5-year survival rate was 47% and 36% for 10-years. Furthermore, for\u00a0patients who presented localized disease, the overall survival was 55% and 41% at 5 and 10 years, respectively. [22] A case series with 52 patients showed a survival rate of 59% and 41% at 5 years and 10 years. [2] Significant prognostic factors include tumor size, depth, and TNM classification. However, after multivariate analysis, only tumor size has remained a significant prognostic factor. [6] [22]"}
{"id": "article-43836_22", "title": "Soft Tissue Clear Cell Sarcoma -- Prognosis", "content": "Another study showed 10% to 14% of patients developing regional lymph node metastasis. A majority of all patients with CCSST eventually developed distant metastasis, most commonly to lung and bone tissue, in addition to regional lymph nodes. [23] Overall, the course of CCSST is regarded as relentless and progressive, usually terminating in widespread metastatic disease. [2]", "contents": "Soft Tissue Clear Cell Sarcoma -- Prognosis. Another study showed 10% to 14% of patients developing regional lymph node metastasis. A majority of all patients with CCSST eventually developed distant metastasis, most commonly to lung and bone tissue, in addition to regional lymph nodes. [23] Overall, the course of CCSST is regarded as relentless and progressive, usually terminating in widespread metastatic disease. [2]"}
{"id": "article-43836_23", "title": "Soft Tissue Clear Cell Sarcoma -- Complications", "content": "While a large percentage of patients present with indolently growing mass in the lower extremity, around 30% to 60% of patients may present pain or tenderness. A minority of patients may present with ulceration of the overlying skin. [6] Untreated CCSST will most likely progress to a widespread deadly metastatic disease. [2]", "contents": "Soft Tissue Clear Cell Sarcoma -- Complications. While a large percentage of patients present with indolently growing mass in the lower extremity, around 30% to 60% of patients may present pain or tenderness. A minority of patients may present with ulceration of the overlying skin. [6] Untreated CCSST will most likely progress to a widespread deadly metastatic disease. [2]"}
{"id": "article-43836_24", "title": "Soft Tissue Clear Cell Sarcoma -- Deterrence and Patient Education", "content": "Although most patients present in their 30s or 40s, the overall prognosis for CCSST is generally regarded as poor. Some patients may appear disease-free after treatment for some time and\u00a0posteriorly develop local recurrence or late metastatic disease with a rapidly fatal progression. Patients should be\u00a0educated about the overall poor prognosis of CCSST, individual risk factors for local or metastatic recurrence, and be\u00a0provided with tumor staging\u00a0before and after treatment. They should also\u00a0be\u00a0encouraged to follow up closely with their healthcare providers. [22]", "contents": "Soft Tissue Clear Cell Sarcoma -- Deterrence and Patient Education. Although most patients present in their 30s or 40s, the overall prognosis for CCSST is generally regarded as poor. Some patients may appear disease-free after treatment for some time and\u00a0posteriorly develop local recurrence or late metastatic disease with a rapidly fatal progression. Patients should be\u00a0educated about the overall poor prognosis of CCSST, individual risk factors for local or metastatic recurrence, and be\u00a0provided with tumor staging\u00a0before and after treatment. They should also\u00a0be\u00a0encouraged to follow up closely with their healthcare providers. [22]"}
{"id": "article-43836_25", "title": "Soft Tissue Clear Cell Sarcoma -- Enhancing Healthcare Team Outcomes", "content": "Patient-centered management should include counseling on diagnostic work-up and treatment choices, individualizing patients with different risk factors for local or distant recurrence. Tumor staging should\u00a0be done early, and\u00a0repeated\u00a0with more information, commonly after excision biopsy, and using the tumor, node, metastasis (TNM) system for patients with soft tissue sarcomas that arise in extremity/trunk. [25]", "contents": "Soft Tissue Clear Cell Sarcoma -- Enhancing Healthcare Team Outcomes. Patient-centered management should include counseling on diagnostic work-up and treatment choices, individualizing patients with different risk factors for local or distant recurrence. Tumor staging should\u00a0be done early, and\u00a0repeated\u00a0with more information, commonly after excision biopsy, and using the tumor, node, metastasis (TNM) system for patients with soft tissue sarcomas that arise in extremity/trunk. [25]"}
{"id": "article-43836_26", "title": "Soft Tissue Clear Cell Sarcoma -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Soft Tissue Clear Cell Sarcoma -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}